Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer

Summary

The proposed study aims to investigate how the administration of a drug known to reduce inflammation in humans, Celecoxib, will effect the peri-operative inflammatory response of a patient undergoing primary tumor resection surgery for colon cancer. The proposed project is an exploratory study, and will use data from blood samples and tumor samples to attempt to elucidate the immune and inflammatory response in colon cancer patients undergoing primary resection of their tumors.

Timeline

Start

2011-01

Primary completion

2011-05

Completion

2011-05

Drugs

Indications